Zuellig Pharma Acquires Leading Brands from Bayer AG
Zuellig Pharma has announced the acquisition of household names Zam-Buk® and Vapex® from Bayer AG, representing a significant growth milestone in its consumer healthcare portfolio.
AstraZeneca Champions Maryland Manufacturing with $2 billion Investment
AstraZeneca is investing $2 billion to develop its biologics facilities in Maryland, advancing the company’s broader drive to bolster manufacturing capabilities across the US.
Strengthening the UK’s Heartbeat: How Wearable Tech Can Transform Cardiology
With cardiovascular diseases being one of the major causes of premature deaths in the UK, cardio monitoring technology is critical, now more than ever, to identifying underlying heart issues and has the potential to transform patient care across the country. We learn more from Jay (David) Wright, Consultant Cardiologist, Liverpool Heart and Chest Hospital, iRhythm Advisor.
